Analysts think CRBP stock price could increase by 364%
Jun 08, 2025, 11:25 AM
-18.90%
What does CRBP do
Corbus Pharmaceuticals, based in Norwood, Massachusetts, focuses on developing therapies for rare inflammatory diseases and cancer, with a pipeline including CRB-701 and CRB-601. The company went public on October 24, 2014, and employs 19 staff.
11 analysts think CRBP stock price will increase by 363.89%. The current median analyst target is $42.84 compared to a current stock price of $9.23. The lowest analysts target is $28.28 and the highest analyst target is $76.65.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
